Markets:

Overview

News

Currencies

International

Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.9800 +0.0800 (+8.89%)

Streaming Delayed Price Updated: 12:48 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 Next >

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗

October 05, 2022

Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.

Via InvestorPlace

Top Medical Specialties Stocks: Trading Opportunities For Next Week - Sunday, Oct. 2 ↗

October 02, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some medical stock opportunities...

Via Talk Markets

Over $2 Million Bet On Cassava Sciences; 4 Stocks Insiders Are Buying ↗

August 17, 2022

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

Recap: TELA Bio Q2 Earnings ↗

August 10, 2022

TELA Bio (NASDAQ:TELA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

TELA Bio: Q4 Earnings Insights ↗

March 21, 2022

TELA Bio (NASDAQ:TELA) reported its Q4 earnings results on Monday, March 21, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed...

Via Benzinga

Preview: TELA Bio's Earnings ↗

March 18, 2022

TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Preview For TELA Bio ↗

August 09, 2022

TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will...

Via Benzinga

TELA Bio to Announce Second Quarter 2022 Financial Results

July 27, 2022

From TELA Bio, Inc.

Via GlobeNewswire

Insiders Buying Joby Aviation And 2 Other Stocks ↗

July 25, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 07, 2022

On Tuesday, 111 companies reached new 52-week lows.

Via Benzinga

TELA Bio: Q1 Earnings Insights ↗

May 10, 2022

TELA Bio (NASDAQ:TELA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed estimated earnings by...

Via Benzinga

ROCE Insights For TELA Bio ↗

May 24, 2021

In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67...

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

Zedge And 2 Other Stocks Insiders Are Buying ↗

April 20, 2022

Although Dow Jones closed higher by around 500 points on Tuesday, there were a few notable insider trades.

Via Benzinga

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

Earnings Scheduled For March 21, 2022 ↗

March 21, 2022

Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

Insiders Buy Around $98M Of 3 Stocks ↗

February 25, 2022

Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W...

Via Benzinga

TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript ↗

November 11, 2021

TELA earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript ↗

August 11, 2021

TELA earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

TELA Bio: Q2 Earnings Insights ↗

August 11, 2021

Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which...

Via Benzinga

Earnings Outlook For TELA Bio ↗

August 10, 2021

On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 14, 2021

Gainers RAPT Therapeutics (NASDAQ:RAPT) s...

Via Benzinga

TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery ↗

May 19, 2021

TELA Bio Inc (NASDAQ: TELA) has launched its second post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Earnings Scheduled For August 11, 2021 ↗

August 11, 2021

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...

Via Benzinga

TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript ↗

May 14, 2021

TELA earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.